Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-13 Sale | 2024-02-15 5:48 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 1,432 | $132.94 | $190,371 | 77,957 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:26 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 126 | $141.94 | $17,884 | 11,843 (Direct) | View |
| 2023-11-29 Sale | 2023-12-01 5:41 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 2,331 | $113.57 | $264,733 | 11,732 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 8:10 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 3,198 | $107.37 | $343,368 | 9,638 (Direct) | View |
| 2023-02-07 Sale | 2023-02-08 7:38 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 4,508 | $102.3 | $461,166 | 6,525 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 5:26 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 126 | $108.48 | $13,668 | 2,477 (Direct) | View |
| 2022-11-29 Sale | 2022-12-01 6:35 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 2,331 | $121.9 | $284,160 | 2,366 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 5:48 pm | N/A 2034-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 64,829 | $0 | 77,957 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:39 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:19 pm | N/A 2033-02-23 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2023-02-27 5:16 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 0 | $0 | 2,910 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:14 pm | N/A 2033-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 78,409 | $0 | 78,409 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:58 pm | N/A 2032-01-31 | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 7,414 | $0 | 7,414 (Direct) | View |
| 2021-11-29 Option Award | 2021-12-01 8:02 pm | N/A 2031-11-29 | NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer | 137,871 | $0 | 137,871 (Direct) | View |